NORTHERN TRUST CORP - TENAX THERAPEUTICS INC ownership

TENAX THERAPEUTICS INC's ticker is and the CUSIP is 88032L209. A total of 19 filers reported holding TENAX THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of TENAX THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$3,862
-35.6%
34,6710.0%0.00%
Q3 2022$6,000
-40.0%
34,6710.0%0.00%
Q2 2022$10,000
-64.3%
34,6710.0%0.00%
Q1 2022$28,000
-22.2%
34,6710.0%0.00%
Q4 2021$36,000
-41.0%
34,6710.0%0.00%
Q3 2021$61,000
-15.3%
34,6710.0%0.00%
Q2 2021$72,000
+125.0%
34,671
+103.7%
0.00%
Q1 2021$32,0000.0%17,0240.0%0.00%
Q4 2020$32,000
+23.1%
17,0240.0%0.00%
Q3 2020$26,000
+136.4%
17,024
+46.2%
0.00%
Q2 2020$11,00011,6420.00%
Other shareholders
TENAX THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
GOFEN & GLOSSBERG LLC /IL/ 3,819,170$6,760,0000.16%
ARMISTICE CAPITAL, LLC 2,019,995$3,575,0000.06%
Ikarian Capital, LLC 466,261$826,0000.06%
Octagon Capital Advisors LP 30,600$54,0000.01%
FAS Wealth Partners, Inc. 58,326$103,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 46,531$82,0000.00%
Gradient Investments LLC 1$00.00%
Hudock, Inc. 1$00.00%
Allworth Financial LP 1$00.00%
VANGUARD GROUP INC 363,069$642,0000.00%
View complete list of TENAX THERAPEUTICS INC shareholders